Skip to main
DAVA

DAVA Stock Forecast & Price Target

DAVA Analyst Ratings

Based on 6 analyst ratings
Hold
Strong Buy 33%
Buy 0%
Hold 50%
Sell 17%
Strong Sell 0%

Bulls say

Endava is expected to see a decline in revenue and sequential adjusted PBT margin expansion in F4Q26, but steady demand and AI adoption by the Global 2000 are expected to drive a +3.0% year-over-year cc revenue growth in FY27, with potential for the shares to re-rate as AI adoption broadens and pipeline conversion normalizes. The company finished the quarter with £48.4 million in cash and £195.8 million in debt, and has repurchased ~8 million ADSs for $121.9 million with $28.1 million remaining, showcasing its strong financial position and commitment to shareholder value.

Bears say

Endava is facing significant challenges in both revenue and profitability, as seen in their F3Q26 results coming in below expectations and their lowered guidance for FY26. The company's high concentration in the UK and Europe, coupled with a large presence in the financial services industry, leaves it vulnerable to economic and political risks such as Brexit. Additionally, the company's reliance on outcome-based work and the decreasing T&M mix could continue to put pressure on margins and overall profitability. These factors lead to a negative outlook on the stock.

DAVA has been analyzed by 6 analysts, with a consensus rating of Hold. 33% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Endava plc - ADR and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Endava plc - ADR (DAVA) Forecast

Analysts have given DAVA a Hold based on their latest research and market trends.

According to 6 analysts, DAVA has a Hold consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Endava plc - ADR (DAVA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.